FindTrial
Sign In

Assessment of anthracyclines-induced cardiotoxicity in childhood with leukemia by cardiac magnetic resonance: clinical prognosis research

Early detect anthracyclines-induced heart injure in childhood with leukemia after chemotherapy by CMR and assess the clinical prognosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017054
Enrollment
Unknown
Registered
2018-07-10
Start date
2018-12-01
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

leukemia

Interventions

leukemia group:no
controls group:no

Sponsors

West China Second University Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: clinical prognosis is leukemia and age less than 18 year old.

Exclusion criteria

Exclusion criteria: 1. Severe renal insufficiency; 2. Contrast allergy; 3. Severe arrhythmia; 4. MRI contraindication.

Design outcomes

Primary

MeasureTime frame
CMR quantitation parameters;—

Countries

China

Contacts

Public ContactGuo Yingkun

West China Second University Hospital, Sichuan University

gykpanda@163.com+86 18980006572

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026